Processa shareholders elect directors, approve equity plan increase and auditor ratification

Processa Pharmaceuticals, Inc.

All six director nominees (Yorke, Ng, Baluch, Neal, Pannu, Young) elected with over 878K 'For' votes each.
Amendment to 2019 Omnibus Incentive Plan increasing share pool by 500,000 shares approved (779,164 for, 176,802 against).
Ratification of BD & Company as independent auditor for 2024 passed with 1,490,908 for, 32,346 against.
Advisory vote on executive compensation approved with 804,087 for, 164,034 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.